Aradigm Corp (ARDM) financial statements (2020 and earlier)

Company profile

Business Address 3929 POINT EDEN WAY
HAYWARD, CA 94545
State of Incorp. CA
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 7233148488
Cash and cash equivalents 7233148487
Short-term investments      0
Restricted cash and investments  1 0  
Receivables 000100
Prepaid expense and other current assets0
Other undisclosed current assets 01411 
Total current assets: 8253551508
Noncurrent Assets
Property, plant and equipment 000101
Other noncurrent assets 0 030
Other undisclosed noncurrent assets      0
Total noncurrent assets: 000311
TOTAL ASSETS: 8253654509
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 333411
Accounts payable 112310
Accrued liabilities 1000 0
Employee-related liabilities 211100
Interest and dividends payable  0    
Restructuring reserve   00
Deferred revenue and credits2 014 
Other undisclosed current liabilities 034221
Total current liabilities: 568771
Noncurrent Liabilities
Long-term debt and lease obligation 1513    
Long-term debt, excluding current maturities 1513    
Liabilities, other than long-term debt 055801
Deferred revenue and credits055800
Restructuring reserve    000
Other undisclosed noncurrent liabilities 0  099
Total noncurrent liabilities: 15185899
Total liabilities: 212413151710
Stockholders' equity
Stockholders' equity attributable to parent (13)1233934(1)
Common stock 443439429427427370
Accumulated deficit (455)(438)(405)(388)(393)(371)
Total stockholders' equity: (13)1233934(1)
TOTAL LIABILITIES AND EQUITY: 8253654509

Income statement (P&L) ($ in millions)

9/30/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenue, net002337136
Gross profit: 1402334106
Operating expenses (21)(30)(41)(37)(30)(8)
Other undisclosed operating loss      (5)
Operating loss: (7)(30)(17)(4)(20)(7)
Nonoperating income (expense) 0(1)(0)(0)(0)0
Investment income, nonoperating 000000
Other nonoperating income (expense) 0(1)(0)(0)(0)(0)
Interest and debt expense (4)(2) 3(2)(2)
Loss from continuing operations before equity method investments, income taxes: (11)(33)(17)(1)(22)(8)
Other undisclosed income from continuing operations before income taxes    6  
Net income (loss): (11)(33)(17)5(22)(8)
Other undisclosed net loss attributable to parent    (0)  
Net income (loss) available to common stockholders, diluted: (11)(33)(17)5(22)(8)

Comprehensive Income ($ in millions)

9/30/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss): (11)(33)(17)5(22)(8)
Comprehensive income (loss): (11)(33)(17)5(22)(8)
Other undisclosed comprehensive loss, net of tax, attributable to parent      (0)
Comprehensive income (loss), net of tax, attributable to parent: (11)(33)(17)5(22)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: